Hexokinase type II: A novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells

Human Gene Therapy

Volumn 10, Issue 2, 1999, Pages 155-164

  Katabi, Maha M ^a,b   Chan, Helen L B ^a,b   Karp, Stephen E ^c   Batist, Gerald ^a,b,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; HEXOKINASE;

ADENOVIRUS; ARTICLE; BREAST CARCINOMA; BRONCHUS MUCOSA; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; GLYCOLYSIS; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NORMAL HUMAN; PROMOTER REGION; REPORTER GENE;

ADENOVIRIDAE; ANIMALS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; GANCICLOVIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; GLUCOSE; HEXOKINASE; HUMANS; LUNG NEOPLASMS; PROMOTER REGIONS (GENETICS); RATS; RNA, MESSENGER; THYMIDINE KINASE;

EID: 0033585463     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018959     Document Type: Article

References (21)

1. ADAMS, V., KEMPF, W., HASSAM, S., and BRINER, J. (1995). Determination of hexokinase isoenzyme I and II composition by RT-PCR: Increased hexokinase isoenzyme II in human renal cell carcinoma. Biochem. Mol. Med. 54, 53-58.
2. BUSTAMANTE, E., and PEDERSEN, P.L. (1977). High aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinase. Proc. Natl. Acad. Sci. U.S.A. 74, 3735-3739.
3. GREENBAUM, M., LETOURNEAU, S., ASSAR, H., SCHECTER, R.L., BATIST, G., and COURNOYER, D. (1994). Retrovirus-mediated gene transfer of rat giutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts. Cancer Res. 54, 4442-4447.
4. HART, I.R. (1996). Tissue specific promoters in targeting systematically delivered gene therapy. Semin. Oncol. 23, 154-158.
5. MATHUPALA, S.P., REMPEL, A., and PEDERSEN, P.L. (1995). Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J. Biol. Chem. 270, 16918-16925.
6. MATHUPALA, S.P., HEESE, C., and PEDERSEN, P.L. (1997). Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J. Biol. Chem. 272, 22776-22780.
7. MOOLTEN, F.L. (1986). Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res. 46, 5276-5281.
8. NAKASHIMA, R.A., PAGGI, M.G., SCOTT, L.J., and PEDERSEN, P.L. (1988). Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line. Cancer Res. 48, 913-919.
9. O'CONNOR, P.M., JACKMAN, J., BAE, I., MYERS, T.G., FAN, S., MUTOH, M., SCUDIERO, D.A., MONKS, A., SAUSVILLE, E.A., WEINSTEIN, J.N., FRIEND, S., FORNACE, A.J.J., and KOHN, K.W. (1997). Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res. 57, 4285-4300.
10. OSAWA, H., PRINTZ, R.L., WHITESELL, R.R., and GRANNER, D.K. (1995). Regulation of hexokinase II gene transcription and glucose phosphorylation by catecholamines, cyclic AMP, and insulin. Diabetes 44, 1426-1432.
11. OSAWA, H., ROBEY, R.B., PRINTZ, R.L., AND GRANNER, D.K. (1996a). Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene. J. Biol. Chem. 271, 17296-17303.
12. OSAWA, H., SUTHERLAND, C., ROBEY, R.B., PRINTZ, R.L., and GRANNER, D.K. (1996b). Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin. J. Biol. Chem. 271, 16690-16694.
13. PLUMB, J.A., MILROY, R., and KAYE, S.B. (1989). Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 49, 4435-4440.
14. REMPEL, A., BANNASCH, P., and MAYER, D. (1994). Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim. Biophys. Acta 1219, 660-668.
15. REMPEL, A., MATHUPALA, S.P., GRIFFIN, C.A., HAWKINS, A.L., and PEDERSEN, P.L. (1996a). Glucose catabolism in cancer cells: Amplification of the gene encoding type II hexokinase. Cancer Res. 56, 2468-2471.
16. REMPEL, A., MATHUPALA, S.P., and PEDERSEN, P.L. (1996b). Glucose catabolism in cancer cells: Regulation of the type II hexokinase promoter by glucose and cyclic AMP. FEBS Lett. 385, 233-237.
17. RING, C.J.A., HARRIS, J.D., HURST, H.C., and LEMOINE, N.R. (1996). Suicide gene expression induced in tumor cells transduced with recombinant adenoviral, retroviral and plasmid vectors containnig the ERBB2 promoter. Gene Ther. 3, 1094-1103.
18. SHINOHARA, Y., ICHIHARA, J., and TERADA, H. (1991). Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130. FEBS Lett. 291, 55-57.
19. SHINOHARA, Y., YAMAMOTO, K., KOGURE, K., ICHIHARA, J., and TERADA, H. (1994). Steady state transcript levels of the type II hexokinase and type 1 glucose transporter in human tumor cell lines. Cancer Lett 82, 27-32.
20. WILSON, J.E. (1985). Regulation of mammalian hexokinase activity. In Regulation of Carbohydrate Metabolism, Vol. I. R. Beitner, ed. (CRC Press, Boca Raton, FL) pp. 45-80.
21. WILSON, J.E. (1995). Hexokinases. Rev. Physiol. Biochem. Pharmacol. 126, 65-198.